Will 111 stock go up?

According to Danelfin AI, 111 has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (45.59%) is -5.23% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for 111 stock?

The 111 target price is $12.25 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold 111 stock right now?

111 has today a Sell rating (AI Score 3/10), according to Danelfin AI. Its probability of beating the market in 3 months (45.59%) is -5.23% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether 111 stock is a good buy .

Is 111 undervalued right now?

Based on analysts, the average price target upside for 111 is +194.36% (1Y). According to Danelfin AI, 111 has today an AI Score of 3/10 (Sell Rating).

What was the price range of 111 stock over the past 12 months?

The 111 stock price range over the past 12 months has been $2.56 - $8.38.

What is going on with 111 stock in the last 3 months?

The 111 stock performance in the last quarter has been -36.19%.

Does 111 offer dividend payments?

No, 111 does not currently pay dividends.

What is the current market capitalization of 111?

111's market cap is $21.49M, as of 2026-07-02 08:00.

When is the next YI earnings report date?

YI will publish its next earnings report on 2026-06-04.

111 Inc (YI) AI Stock Analysis

Advanced Chart

Custom range

Jul 2, 2025

→

Jul 2, 2026

Custom range

Jul 2, 2025

→

Jul 2, 2026

YI AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score

Sell

111 (YI) has an AI Score of 3/10 (Sell) because, according to an overall analysis, it has a probability advantage of -5.23% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of YI (45.59%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
YI probability advantage of beating the market (3M)-5.23%
YI probability of beating the market (3M)45.59%

YI probability advantage of beating the market (3M): -5.23%

The AI-powered overall analysis of 111 (YI) is based on the 28 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of YI:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	-4.16%
Technical	Technicals Impact (Long Tail)	-	N/A	+1.89%
Sentiment	Country	China	N/A	-1.70%
Fundamental	Operating Cash Flow (Qtr Discrete)	-13.3		+1.58%
Technical	Maximum Volatility	15.11%		-1.44%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	3.08		-1.42%
Technical	Chart Pattern (504d)	figure_7	N/A	+1.30%
Technical	Chart Pattern (252d)	figure_53	N/A	-1.27%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-1.17%
Sentiment	Institutional Transactions (3m Change)	-56.28%	N/A	+1.06%
Technical	Upgrade to unlock			+1.01%
Technical	Upgrade to unlock			-0.98%
Technical	Upgrade to unlock			+0.92%
Sentiment	Upgrade to unlock			-0.87%
Sentiment	Upgrade to unlock			-0.78%

Rest of Alpha Signals: +0.81%

YI probability advantage of beating the market (3M)Total:-5.23%
YI AI Score

Significant changes Vs previous day

YI Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$4.16
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

YI Proven Sell Signal & Price Forecast

This is the price chart for YI from January 1, 2026 until today. The chart indicates, in red, the 15 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

YI Average Past Performance & Loss Rate

Three months after its 598 Sell signals since July 2026, YI had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

598 Past YI Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+1.72%
Average Alpha				-6.81%
Loss Rate (% Negative Perf.)				57.95%
% Negative Alpha				58.14%

YI Frequently Asked Questions

Will 111 stock go up?
According to Danelfin AI, 111 has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (45.59%) is -5.23% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for 111 stock?
Is it a good time to buy, sell, or hold 111 stock right now?
Is 111 undervalued right now?
What was the price range of 111 stock over the past 12 months?
What is going on with 111 stock in the last 3 months?
Does 111 offer dividend payments?
What is the current market capitalization of 111?
When is the next YI earnings report date?

111 Inc Company Profile

Incorporating a nexus of online and offline resources, 111, Inc., along with its subsidiaries, holds a fundamental position within China's healthcare market. The organization operates via two distinct channels - B2C and B2B. It merchandises a broad range of medical goods through online retail outlets as well as physical wholesale and retail pharmacies.

The company's offerings consist of prescription and OTC drugs inclusive of Western and traditional Chinese medicines; dietary auxiliaries like vitamins; optical accessories such as contact lenses, varied medical supplies like bandages and thermometers, and personal care products engulfing skincare items, contraceptive solutions, sexual health essentials, as well as baby care commodities.

Moreover, 111, Inc facilitates an e-commerce platform where independent vendors directly engage with pharmacies while simultaneously providing loan application services to the clienteles of their settled division – 1 Pharmacy – including pharmacies themselves or wholesalers. It further offers data management alongside comprehensive supply chain integration services.

In addition to this array of services closer to its core mandate, it also provides logistical assistance including warehousing provisions; the domain extends to procurement processes leading up to offering software development plus IT support services. This is all supplemented by research & development efforts coupled with consultation services for enhanced customer experience.

For its physical footprint in the healthcare market, 111 Inc manages brick-and-mortar stores under the banner of Yi Hao Pharmacy across several provinces in China namely Guangzhou, Tianjin, Kunshan, Chongqing & Wuhan. This widespread network caters to a rich clientele ranging from pharmacists and pharmaceutical organizations to medical professionals and insurance enterprises alike.

The corporation was originally recognized as New Peak Group before decamping into the current title i.e. 111 Inc in April 2018. Set up initially in the year 2010 has since had its operational headquarters in Shanghai within the magnanimous People’s Republic of China.

Sector:Consumer Staples
Country:China
Industry:
Address:3-4/F, No.295 Zuchongzhi Road, Pudong New Area, Shanghai
Employees:1,063
Website:corporate.111.com.cn

Pros

Expanding e-commerce penetration in pharmaceutical distribution

Two-sided marketplace network effects for suppliers and consumers

Favorable demographic trends from an aging population

Government policy support for digital healthcare services

Scalable technology platform for broad geographic reach

Cons

High competitive intensity in online pharmacy market

Evolving regulatory landscape for online medical services

Complex supply chain management for pharmaceutical products

Low consumer switching costs among online health platforms

Potential for data privacy breaches in health information

Pros

Cons

Company

AI Score

Compare

RDGTRidgetech Inc

ACIAlbertsons Companies Inc

WMTWalmart Inc

TGTTarget Corp

BJBJ's Wholesale Club Holdings Inc

Company

AI Score

Compare

	Company	AI Score	Compare
1	ANDEAndersons Inc

Company

AI Score

Compare

ANDEAndersons Inc

Company

AI Score

Compare

	Company	AI Score	Compare
1	SEBSeaboard Corp

Company

AI Score

Compare

SEBSeaboard Corp

Company

AI Score

Compare

YI Stock AI Analysis

111 Inc

YI Stock AI Analysis

111 Inc

YI AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

AI Score Explanation

Generating AI Score explanation

Alpha Signals: What Drives the AI Score

YI probability advantage of beating the market (3M): -5.23%

YI Short Trading Parameters

YI Proven Sell Signal & Price Forecast

YI Average Past Performance & Loss Rate

YI Frequently Asked Questions

Will 111 stock go up?

What is the target price for 111 stock?

Is it a good time to buy, sell, or hold 111 stock right now?

Is 111 undervalued right now?

What was the price range of 111 stock over the past 12 months?

What is going on with 111 stock in the last 3 months?

Does 111 offer dividend payments?

What is the current market capitalization of 111?

When is the next YI earnings report date?

111 Inc Company Profile

Pros

Cons

Pros

Cons

YI Company Profile Summary

YI Related Investment Themes

YI Related Stocks

YI Top 10 Industry Stocks

Consumer Staples Distribution & Retail

YI Top 10 Sector Stocks

Consumer Staples

YI Stock AI Analysis

111 Inc

NASDAQ NMS - GLOBAL MARKET

Will 111 stock go up?

What is the target price for 111 stock?

Is it a good time to buy, sell, or hold 111 stock right now?

Is 111 undervalued right now?

What was the price range of 111 stock over the past 12 months?

What is going on with 111 stock in the last 3 months?

Does 111 offer dividend payments?

What is the current market capitalization of 111?

When is the next YI earnings report date?

NASDAQ NMS - GLOBAL MARKET

AI Score Explanation

Generating AI Score explanation

Pros

Cons

YI Proven Sell Signal & Price Forecast